MAGEL2

Chr 15AD

MAGE family member L2

Also known as: NDNL1, PWLS, SHFYNG, nM15

MAGEL2 encodes a protein that functions in early endosomes and is paternally imprinted within the Prader-Willi syndrome chromosomal region at 15q11-q13. Mutations cause Schaaf-Yang syndrome, which follows an autosomal dominant inheritance pattern. The protein is highly intolerant to loss-of-function mutations, suggesting haploinsufficiency as the likely pathogenic mechanism.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismADLOEUF 0.311 OMIM phenotype
Clinical SummaryMAGEL2
🧬
Gene-Disease Validity (ClinGen)
Schaaf-Yang syndrome · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.98). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
40 unique Pathogenic / Likely Pathogenic· 382 VUS of 500 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available
📖
GeneReview available — MAGEL2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint
0.31LOEUF
pLI 0.975
Z-score 3.75
OE 0.10 (0.040.31)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
-0.56Z-score
OE missense 1.08 (1.001.18)
399 obs / 368.6 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.10 (0.040.31)
00.351.4
Missense OE1.08 (1.001.18)
00.61.4
Synonymous OE1.17
01.21.6
LoF obs/exp: 2 / 20.2Missense obs/exp: 399 / 368.6Syn Z: -1.72
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveMAGEL2-related Schaaf-Yang syndromeLOFAD
DN
0.4190th %ile
GOF
0.3193th %ile
LOF
0.58top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF48% of P/LP variants are LoF · LOEUF 0.31
DN1 literature citation

Literature Evidence

DNThe concept that a deletion of the entire gene could have milder effects than a truncating mutation is intriguing. Because MAGEL2 is a one-exon gene, one could speculate that truncating mutations may result in a truncated protein, which then could have a dominant-negative effect.PMID:27195816

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

500 submitted variants in ClinVar

Classification Summary

Pathogenic22
Likely Pathogenic18
VUS382
Likely Benign58
Benign1
Conflicting19
22
Pathogenic
18
Likely Pathogenic
382
VUS
58
Likely Benign
1
Benign
19
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
4
0
18
0
22
Likely Pathogenic
15
1
2
0
18
VUS
7
310
8
57
382
Likely Benign
0
14
0
44
58
Benign
0
0
0
1
1
Conflicting
19
Total2632528102500

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MAGEL2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 5 results · since 2015Search PubMed ↗